Am J Perinatol 2017; 34(11): 1125-1130
DOI: 10.1055/s-0037-1604161
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prophylactic Wound Vacuum Therapy after Cesarean Section to Prevent Wound Complications in the Obese Population: A Randomized Controlled Trial (the ProVac Study)

Kelly Ruhstaller
1   Department of Obstetrics and Gynecology, Maternal Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
,
Katheryne L. Downes
1   Department of Obstetrics and Gynecology, Maternal Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
,
Suchitra Chandrasekaran
2   Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington
,
Sindhu Srinivas
1   Department of Obstetrics and Gynecology, Maternal Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
,
Celeste Durnwald
1   Department of Obstetrics and Gynecology, Maternal Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
› Institutsangaben
Weitere Informationen

Publikationsverlauf

16. Mai 2017

05. Juni 2017

Publikationsdatum:
13. Juli 2017 (online)

Abstract

Objective The objective of this study was to perform a randomized controlled feasibility trial investigating negative pressure wound therapy (NPWT) system versus a standard postcesarean wound care (WC) on the development of a postoperative surgical site infection (SSI) and/or a wound dehiscence in obese women.

Study Design This is a randomized controlled feasibility trial of obese women undergoing an unscheduled cesarean delivery. Women with an initial body mass index ≥ 30 kg/m2 who were ≥ 4 cm dilated were included. Women were assigned to either a NPWT or standard WC. The primary outcome was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening (clinicaltrials.gov, NCT02128997). Continuous variables were analyzed with t-test and Wilcoxon rank-sum tests and categorical variables with Fisher's exact test.

Results Of 136 women randomized, 67 received NPWT and 69 received standard WC. The 4-week follow-up rate was 88%. Maternal clinical and surgical characteristics were similar between the groups. The prevalence of the composite wound morbidity outcome was not different between those with NPWT and standard WC (4.9 vs. 6.9%; p = 0.71).

Conclusion Routine clinical use of a NPWT system after cesarean delivery did not result in a significant reduction of wound morbidity over standard WC.

Note

This study was presented at the 37th Annual Meeting of the Society for Maternal Fetal Medicine, Las Vegas, NV, January 25–27, 2017.


Clinical Trials Registration

The clinical trial was registered at https://clinicaltrials.gov/, NCT02128997.


 
  • References

  • 1 Krieger Y, Walfisch A, Sheiner E. Surgical site infection following cesarean deliveries: trends and risk factors. J Matern Fetal Neonatal Med 2017; 30 (01) 8-12
  • 2 Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014; (10) CD007482
  • 3 Tuuli MG, Liu J, Stout MJ. , et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016; 374 (07) 647-655
  • 4 Olsen MA, Butler AM, Willers DM, Gross GA, Hamilton BH, Fraser VJ. Attributable costs of surgical site infection and endometritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol 2010; 31 (03) 276-282
  • 5 Kominiarek MA, Vanveldhuisen P, Hibbard J. , et al; Consortium on Safe Labor. The maternal body mass index: a strong association with delivery route. Am J Obstet Gynecol 2010; 203 (03) 264.e1-264.e7
  • 6 Huang C, Leavitt T, Bayer LR, Orgill DP. Effect of negative pressure wound therapy on wound healing. Curr Probl Surg 2014; 51 (07) 301-331
  • 7 Stannard JP, Volgas DA, McGwin III G. , et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma 2012; 26 (01) 37-42
  • 8 Grauhan O, Navasardyan A, Hofmann M, Müller P, Stein J, Hetzer R. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg 2013; 145 (05) 1387-1392
  • 9 Anglim B, O'Connor H, Daly S. Prevena™, negative pressure wound therapy applied to closed Pfannenstiel incisions at time of caesarean section in patients deemed at high risk for wound infection. J Obstet Gynaecol 2015; 35 (03) 255-258
  • 10 Swift SH, Zimmerman MB, Hardy-Fairbanks AJ. Effect of single-use negative pressure wound therapy on postcesarean infections and wound complications for high-risk patients. J Reprod Med 2015; 60 (5-6): 211-218
  • 11 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 12 Connelly LM. Pilot studies. Medsurg Nurs 2008; 17 (06) 411-412
  • 13 Rouse DJ. Prophylactic negative pressure wound therapy: we need proof before application. Obstet Gynecol 2015; 125 (02) 297-298